Terms: = Uterine cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862
935 results:
1. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract] [Full Text] [Related]
2. Knowledge Mapping of Cowden Syndrome: a Bibliometric Analysis.
Peng Q; Duan N; Wang X; Wang WM
Chin J Dent Res; 2024 Mar; 27(1):75-82. PubMed ID: 38546522
[TBL] [Abstract] [Full Text] [Related]
3. Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs.
Santoro A; Bragantini E; Castiglione F; Ganesan R; Matias-Guiu X; Frattini M; Gallotta V; Garcia P; Pattni Y; Tsiampali-Laprell J; Bisaro B; Barbareschi M; Zannoni GF;
Pathologica; 2024 Feb; 116(1):32-45. PubMed ID: 38482673
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.
Jassar A; Hemali N; Bhatnagar A
Indian J Pathol Microbiol; 2024; 67(1):68-73. PubMed ID: 38358191
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
Makker V; Taylor MH; Aghajanian C; Cohn AL; Brose MS; Simone CD; Cao ZA; Suttner L; Loboda A; Cristescu R; Jelinic P; Orlowski R; Dutta L; Matsui J; Dutcus CE; Minoshima Y; Messing MJ
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38242717
[TBL] [Abstract] [Full Text] [Related]
6. Metformin exhibits antineoplastic effects on pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.
Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
[TBL] [Abstract] [Full Text] [Related]
7. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
[TBL] [Abstract] [Full Text] [Related]
8. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
9. [Fertility-preserving treatment outcomes in endometrial cancer and atypical hyperplasia patients with different molecular profiles].
Shao WY; Dong YT; Lyu QY; Liao JB; Xue Y; Chen XJ
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):742-754. PubMed ID: 37849255
[No Abstract] [Full Text] [Related]
10. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
Reid K; Camacho-Vanegas O; Pandya D; Camacho SC; Qiao RF; Kalir T; Padron-Rhenals MM; Beddoe AM; Dottino P; Martignetti JA
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37848227
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.
Jamieson A; Vermij L; Kramer CJH; Jobsen JJ; Jürgemlienk-Schulz I; Lutgens L; Mens JW; Haverkort MAD; Slot A; Nout RA; Oosting J; Carlson J; Howitt BE; Ip PPC; Lax SF; McCluggage WG; Singh N; McAlpine JN; Creutzberg CL; Horeweg N; Gilks CB; Bosse T
Clin Cancer Res; 2023 Dec; 29(23):4949-4957. PubMed ID: 37773079
[TBL] [Abstract] [Full Text] [Related]
12. In Vivo Intra-uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of pten/p53-Deficient Endometrial cancers.
Navaridas R; Vidal-Sabanés M; Ruiz-Mitjana A; Altés G; Perramon-Güell A; Yeramian A; Egea J; Encinas M; Gatius S; Matias-Guiu X; Dolcet X
Adv Sci (Weinh); 2023 Nov; 10(32):e2303134. PubMed ID: 37749866
[TBL] [Abstract] [Full Text] [Related]
13. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
14. Genomic profile of Chinese patients with endometrial carcinoma.
Li J; Li X; Quan C; Li X; Wan C; Wu X
BMC Cancer; 2023 Sep; 23(1):888. PubMed ID: 37730563
[TBL] [Abstract] [Full Text] [Related]
15. The prognostic significance of the heterologous component in uterine carcinosarcomas.
Can B; Karataşli V; Çakir İ; Sayhan S; Hansu K; Kuru O
Rev Assoc Med Bras (1992); 2023; 69(9):e20230517. PubMed ID: 37729375
[TBL] [Abstract] [Full Text] [Related]
16. Cholesterol biogenesis is a pten-dependent actionable node for the treatment of endocrine therapy-refractory cancers.
Kaysudu I; Gungul TB; Atici S; Yilmaz S; Bayram E; Guven G; Cizmecioglu NT; Sahin O; Yesiloz G; Haznedaroglu BZ; Cizmecioglu O
Cancer Sci; 2023 Nov; 114(11):4365-4375. PubMed ID: 37706278
[TBL] [Abstract] [Full Text] [Related]
17. Molecular biological analysis revealed a case of synchronous endometrial and ovarian cancer with different histological grade as metastatic ovarian cancer from endometrial cancer: Case report and review of literature.
Yumisashi R; Saito R; Togami S; Kobayashi Y; Kitazono I; Tanimoto A; Kobayashi H
J Obstet Gynaecol Res; 2023 Nov; 49(11):2766-2770. PubMed ID: 37604499
[TBL] [Abstract] [Full Text] [Related]
18. Knockdown of miR-24 Suppressed the Tumor Growth of Cervical Carcinoma Through Regulating pten/PI3K/AKT Signaling Pathway.
He H; Lin C; Lu Y; Wu H
Biochem Genet; 2024 Apr; 62(2):1277-1290. PubMed ID: 37589947
[TBL] [Abstract] [Full Text] [Related]
19. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis.
Brown M; Leon A; Kedzierska K; Moore C; Belnoue-Davis HL; Flach S; Lydon JP; DeMayo FJ; Lewis A; Bosse T; Tomlinson I; Church DN
EMBO Mol Med; 2023 Oct; 15(10):e17094. PubMed ID: 37589076
[TBL] [Abstract] [Full Text] [Related]
20. Alteration of tumor suppressors changes the endometrial tumor spectrum.
Mayo LD
EMBO Mol Med; 2023 Oct; 15(10):e18166. PubMed ID: 37587857
[TBL] [Abstract] [Full Text] [Related]
[Next]
